THE DIFFERENCE IS
AC5® SYNTHETIC SELF-ASSEMBLING PEPTIDE TECHNOLOGY
SEE HOW IT WORKS
PLAY MOA VIDEO
AC5® Advanced Wound System is a POWERFUL matrix for managing challenging wounds.
With demonstrated effectiveness in even the most challenging wounds, AC5® Advanced Wound System is changing the healing experience.
Patient: 59 year old female
Origin: A non-healing trophic ulcer on the left lateral malleolus. The patient had a complex medical history with multiple systemic comorbidities, including lupus, scleroderma with Raynaud’s phenomenon, small vessel peripheral vascular disease, and right below-the-knee amputation secondary to small vessel disease and a prior non-healing ulcer.
Prior Failed Therapy: Debridement, moist wound healing, nitro paste, and other skin substitutes
Result: After 2 weekly treatments, the ulcer showed dramatic healing results, demonstrated by a greater than 90% reduction in wound volume. By day 19, the wound was completely epithelialized.
Patient: 66 year old female
Origin: Non-healing surgical site wound from local infection and wound dehiscence. Due to peripheral arterial disease the patient was not a candidate for compression dressings.
Prior Failed Therapy: Wet to dry dressings, collagenase ointment, and skin graft
Result: After 3 weekly treatments, the ulcer showed the formation of a healthy granulation tissue, thus allowing the patient to resume at-home wound care. The development of a stable granular wound bed and wound closure was achieved without the need for additional skin grafts.
Patient: 51 year old male
Origin: A non-healing surgical wound of the pre-tibial, right lower leg. The patient has a history of chronic deep vein thrombosis causing a right pulmonary artery chronic thrombus and idiopathic mediastinal fibrosis, as well as hypertension and dyspnea.
Prior Failed Therapy: Various topical antibiotics and non-adhesive pads
Result: After 4 weekly treatments with debridement, granulation tissue increased, the wound surface area progressively decreased 90% by the final application, and the wound had completely healed by the final follow-up visit at week six.
Patient: 49 year old male
Origin: A chronic open friable wound due to the breakdown of severe scarring. The initial injury was an extensive burn across chest and flank that had occurred over two decades ago. The extreme friability of the wound, coupled with its presence in areas prone to continued friction with clothing, led to frequent and extensive bleeding.
Prior Failed Therapy: Repeat surgical debridement, APG (antibiofilm gel), non-adherent foams and dressings
Result: After only two treatments, the wound bed quality improved exhibiting a healthier tissue appearance, less exudate, less accumulation of slough on the wound surface, and new evidence of granulation buds. Cessation of intermittent bleeding episodes was noted, thus alleviating the burden of at-home wound care.
Patient: 47 year old male
Origin: An ischial decubitus ulcer that would not heal during the prior decade of standard care. The wound was subjected to repetitive trauma due to operation of heavy equipment, thus exacerbating the need for wound management. Wound microbiota included staphylococcus, Pseudomonas, and Candida.
Prior Failed Therapy: Topical agents and dressings
Result: After 6 weeks of every other week treatment with debridement, the wound approached 50% reduction in volume. Each dressing change required less packing and the significant reduction in drainage and bleeding resulted in easier at-home wound care with fewer in-between clinic visits. The wound improved even though the patient continued to be immobile and this encouraged the patient to adhere to scheduled clinic visits, thus allowing for continued care and healing.
Patient: 65 year old male
Origin: A transmetatarsal amputation for gangrenous toes that slowly began to fail and had extensive dry and wet gangrene present. The patient had a history of hypertension, dialysis dependent renal failure, coronary artery bypass, and status post left below knee amputation.
Prior Failed Therapy: BKA post-op dressing changes
Result: After 3 weekly treatments with debridements and daily dressing changes, the wound shrank from 4 x 3 inches to 3 x 1.5 inches with a near 90% coverage of healthy pink granulation tissue. The serosanguinous drainage initially present also nearly abated and peripheral dry gangrene considerably diminished.
Listen to wound care experts discuss how AC5® Advanced Wound System Wound is changing the healing experience.
AC5® Advanced Wound System is simple to store and easy to apply.
Qty | Description of Sterilized Contents |
---|---|
1 | AC5® Peptide Vial (3mL) |
1 | Water Vial (10 mL) |
1 | Syringe with Luer-Lok™ Tip (3mL) |
2 | Hypodermic Needle (18G x 1.5in) |
1 | Blunt Applicator (18G x 1.5in) |
2 | Alcohol Prep Pad (2 ply, medium, saturated with 70% isopropyl alcohol) |
Please complete the following and we will promptly connect with you.